MONTREAL For the last few years, 62-year-old Montreal resident Yves Monette has spent precious time engaging with doctors and legislators not to ask them for help to save his life, but to get the necessary authorization to end it. The former prison guard, security expert, and martial arts aficionado was repeatedly denied medical assistance in dying because he didn’t meet some of the criteria contained in the federal legislation. In April of this year, however, shortly after the legislation was amended, Monette was granted permission to obtain medical aid to die and is scheduled to receive that assistance from a qualified doctor on Wednesday.
Family wants answers after Quebec woman posts video begging for help in hospital, dies 2 days later
The Quebec coroner is investigating the death of Mireille Ndjomouo, who posted a video on social media two days before her death claiming that staff at Charles-Le Moyne hospital in Longueuil had given her penicillin despite her being allergic.
Social Sharing
CBC News ·
Posted: Mar 13, 2021 9:03 PM ET | Last Updated: March 14
Mireille Ndjomouo posted a video in visible distress from a hospital bed in Longueuil two days before her death. (Justice Pour Mireille Ndjomouo/Facebook)
The Quebec coroner is investigating the death of Mireille Ndjomouo, who posted a video on social media two days before she died claiming staff at a hospital on Montreal s South Shore had ignored her allergies.
Drug cost guidelines putting a price on a patient s life, says blood-disorder group If a drug is clinically proven to drastically alter a patient’s quality of life and, in some cases, give them a life equal to that of a normal healthy person, what price do you put on that? asks Montrealer Barry Katsof.
Author of the article: Susan Schwartz • Montreal Gazette
Publishing date: Dec 16, 2020 • December 16, 2020 • 3 minute read • Audrey Lagacé, a nurse at Charles-Le Moyne Hospital, has taken an expensive medication to control a life-threatening blood disorder. She is concerned that plans for a national pharmacare program will mean clinical trials for diseases like hers will stop. Photo by John Mahoney /Montreal Gazette